NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 42 filers reported holding NEXTCURE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,971 | -68.4% | 4,629 | -55.8% | 0.00% | – |
| Q2 2023 | $18,869 | -68.3% | 10,483 | -73.9% | 0.00% | – |
| Q1 2023 | $59,494 | +179.9% | 40,198 | +166.7% | 0.00% | – |
| Q4 2022 | $21,256 | -97.7% | 15,075 | -95.5% | 0.00% | – |
| Q3 2022 | $926,000 | -41.5% | 336,900 | 0.0% | 0.00% | – |
| Q2 2022 | $1,583,000 | +79050.0% | 336,900 | +134660.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 250 | -42.0% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 431 | +30.2% | 0.00% | – |
| Q2 2021 | $3,000 | -98.1% | 331 | -97.9% | 0.00% | – |
| Q1 2021 | $155,000 | -9.4% | 15,490 | -1.3% | 0.00% | – |
| Q4 2020 | $171,000 | -86.9% | 15,690 | -89.4% | 0.00% | – |
| Q3 2020 | $1,307,000 | -59.0% | 148,490 | 0.0% | 0.00% | – |
| Q2 2020 | $3,184,000 | -42.2% | 148,490 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $5,505,000 | -34.2% | 148,490 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $8,364,000 | – | 148,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,671,856 | $16,031,000 | 0.94% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 193,012 | $1,158,000 | 0.47% |
| DAFNA Capital Management LLC | 187,696 | $1,126,000 | 0.28% |
| Sio Capital Management, LLC | 130,000 | $780,000 | 0.24% |
| Orbimed Advisors | 2,711,013 | $16,266,000 | 0.21% |
| Long Focus Capital Management, LLC | 225,000 | $1,350,000 | 0.18% |
| Lombard Odier Asset Management (Switzerland) SA | 407,291 | $2,444,000 | 0.16% |
| Ikarian Capital, LLC | 134,055 | $804,000 | 0.12% |
| Minerva Advisors LLC | 31,713 | $190,000 | 0.11% |
| Anson Funds Management LP | 115,328 | $692,000 | 0.07% |